SI-BONE, Inc. SIBN 深 沪
交易中 03-27 11:58:19 美东时间
12.6416
-0.198
-1.55%
华盛通- 最 高15.66
- 今 开12.77
- 成交量 4789股
- 最 低 12.47
- 昨 收 12.84
- 总市值 42.87万
- 52周最高 21.89
- 市盈率 静 --
- 换手率 14.12%
- 52周最低 12.47
- 委 比 62.50%
- 总股本 3.39万
- 历史最高 37.21
- 量 比 0.03
- 振 幅 24.84%
- 历史最低 1.10
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多SI-BONE Q4 Earnings Assessment
SI-BONE (NASDAQ:SIBN) reported its Q4 earnings results on Monday, February 23, ...
02-24 05:12
Earnings Scheduled For February 23, 2026
Companies Reporting Before The Bell • Domino's Pizza (NASDAQ:DPZ) is likely to ...
02-23 19:11
A Glimpse Into The Expert Outlook On SI-BONE Through 5 Analysts
In the last three months, 5 analysts have published ratings on SI-BONE (NASDAQ:...
01-27 22:01
Why Did SI-Bone (SIBN) Surge Spike After Hours?
SI-Bone shares rose in after-hours trading as three executives sold stock last week to cover RSU tax obligations.
01-07 14:53
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
2025-11-10 19:12
SI-BONE to Truist Securities MedTech Conference on June 17, 2025
SI-BONE to Participate in 2025 Truist Securities MedTech Conference, featuring a fireside chat by management on June 17. Investors can access the event online.
2025-06-04 20:30
SI-BONE to Present at Goldman Sachs 46th Global Healthcare Conference on June 10, 2025
SI-BONE, Inc. will participate in the 2025 Goldman Sachs Global Healthcare Conference in Miami Beach, with management hosting a fireside chat on June 10, 2025. Investors can access the webcast through a provided link or on the company's website, with an archived version available for 90 days. SI-BONE is a global leader in developing technologies for sacropelvic disorder treatments, having supported over 120,000 procedures since 2009.
2025-05-28 20:30
SI-Bone's iFuse Implant System Receives 510(K) Clearance, Breakthrough Device Designation From FDA
09:27 AM EDT, 08/20/2024 (MT Newswires) -- SI-Bone (SIBN) said Tuesday that it has received 510(k) clearance and Breakthrough Device Designation from the US Food and Drug Administration for its iFuse TORQ TNT Implant System. The 501(k) clearance designates new devices that the regulator determines a...
2024-08-20 21:27
